Literature DB >> 11092820

Chasing the cancer demon.

A G Knudson1.   

Abstract

Boveri's idea that somatic mutations are at the root of cancer found its first specific support with the investigation of leukemia and Burkitt's lymphoma, and the discovery of the mechanism of oncogene activation by balanced translocation. The study of retinoblastoma later led to the cloning of the first antioncogene, or tumor suppressor gene, and to understanding the mechanisms by which the wild-type genes lose activity. Only a small subset of cancer involves simple mechanisms. A category of hereditary disorders called the phakomatoses provide a perspective on the chain of oncogenic events in such cancers because of two-hit precursor lesions that have a low probability of malignant transformation. The common carcinomas are much more complex and are typically genetically unstable, owing either to mutational instability or chromosomal instability.

Entities:  

Mesh:

Year:  2000        PMID: 11092820     DOI: 10.1146/annurev.genet.34.1.1

Source DB:  PubMed          Journal:  Annu Rev Genet        ISSN: 0066-4197            Impact factor:   16.830


  21 in total

1.  Molecular structure of double-minute chromosomes bearing amplified copies of the epidermal growth factor receptor gene in gliomas.

Authors:  Nicolas Vogt; Sandrine-Hélène Lefèvre; Françoise Apiou; Anne-Marie Dutrillaux; Andrej Cör; Pascal Leuraud; Marie-France Poupon; Bernard Dutrillaux; Michelle Debatisse; Bernard Malfoy
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-21       Impact factor: 11.205

2.  Age-specific incidence of cancer: Phases, transitions, and biological implications.

Authors:  Rafael Meza; Jihyoun Jeon; Suresh H Moolgavkar; E Georg Luebeck
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-20       Impact factor: 11.205

3.  mTORC2 is required for proliferation and survival of TSC2-null cells.

Authors:  Elena A Goncharova; Dmitry A Goncharov; Hua Li; Wittaya Pimtong; Stephen Lu; Irene Khavin; Vera P Krymskaya
Journal:  Mol Cell Biol       Date:  2011-04-11       Impact factor: 4.272

Review 4.  New insights of extrachromosomal DNA in tumorigenesis and therapeutic resistance of cancer.

Authors:  Hui Qiu; Zhi-Ying Shao; Xin Wen; Long-Zhen Zhang
Journal:  Am J Cancer Res       Date:  2020-12-01       Impact factor: 6.166

5.  The promoter hypermethylation status of GATA6, MGMT, and FHIT in glioblastoma.

Authors:  Gulsah Cecener; Berrin Tunca; Unal Egeli; Ahmet Bekar; Gulcin Tezcan; Elif Erturk; Nuran Bayram; Sahsine Tolunay
Journal:  Cell Mol Neurobiol       Date:  2011-09-18       Impact factor: 5.046

Review 6.  Cellular senescence: a link between cancer and age-related degenerative disease?

Authors:  Judith Campisi; Julie K Andersen; Pankaj Kapahi; Simon Melov
Journal:  Semin Cancer Biol       Date:  2011-09-10       Impact factor: 15.707

7.  Neurofibromas in NF1: Schwann cell origin and role of tumor environment.

Authors:  Yuan Zhu; Pritam Ghosh; Patrick Charnay; Dennis K Burns; Luis F Parada
Journal:  Science       Date:  2002-05-03       Impact factor: 47.728

Review 8.  Epigenomics and ovarian carcinoma.

Authors:  Leonel Maldonado; Mohammad Obaidul Hoque
Journal:  Biomark Med       Date:  2010-08       Impact factor: 2.851

Review 9.  Epigenomics and breast cancer.

Authors:  Pang-Kuo Lo; Saraswati Sukumar
Journal:  Pharmacogenomics       Date:  2008-12       Impact factor: 2.533

10.  Scaffold Attachment Factor B1 (SAFB1) heterozygosity does not influence Wnt-1 or DMBA-induced tumorigenesis.

Authors:  Benny Abraham Kaipparettu; Klaudia M Dobrzycka; Ora Britton; Adrian V Lee; Alan J Herron; Yi Li; Michael T Lewis; Daniel Medina; Steffi Oesterreich
Journal:  Mol Cancer       Date:  2009-03-06       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.